Literature DB >> 7040526

Systemic effects of epinephrine-impregnated retraction cord in fixed partial denture prosthodontics.

W T Buchanan, K E Thayer.   

Abstract

There still is conflict among practitioners and researchers concerning the systemic effects of epinephrine retraction systems. However, the concentration of epinephrine in our commercially available retraction systems, as reported by Shaw, is cause for concern. Therefore, before using these systems, the dentist must consider the following variables: medical history of the patient, health of the oral cavity (especially the dentogingival unit), type of procedure to be done, amount and length of retraction, and exposure of the vascular bed. After careful attention to the foregoing variables, the retraction system of choice is the 8% racemic epinephrine-impregnated retraction cord. In addition to these variables, a calm and organized manner in the dental operatory can and will reassure the patient of the best of care with the least side effects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040526     DOI: 10.14219/jada.archive.1982.0219

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  3 in total

1.  Clinical evaluation of three new gingival retraction systems: a research report.

Authors:  Ankit Gupta; D R Prithviraj; Deepti Gupta; D P Shruti
Journal:  J Indian Prosthodont Soc       Date:  2012-07-08

2.  In vitro effects of vasoconstrictive retraction agents on primary human gingival fibroblasts.

Authors:  Danuta Nowakowska; Jolanta Saczko; Anna Szewczyk; Olga Michel; Marek Ziętek; Joanna Weżgowiec; Włodzimierz Więckiewicz; Julita Kulbacka
Journal:  Exp Ther Med       Date:  2020-01-20       Impact factor: 2.447

3.  Effect of conventional and experimental gingival retraction solutions on the tensile strength and inhibition of polymerization of four types of impression materials.

Authors:  Sérgio Sábio; Paulo Afonso Franciscone; José Mondelli
Journal:  J Appl Oral Sci       Date:  2008 Jul-Aug       Impact factor: 2.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.